Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: A single institution experience in China

Annals of Hematology

Volumn 90, Issue 3, 2011, Pages 331-341

  Liu, Qi Fa ^a   Xu, Xiao Jun ^a   Chen, Yin Kui ^a   Sun, Jing ^a   Zhang, Yu ^a   Fan, Zhi Ping ^a   Xu, Dan ^a   Jiang, Qian Li ^a   Wei, Yong Qiang ^a   Huang, Fen ^a   Feng, Ru ^a   Liu, Xiao Li ^a   Xu, Bing ^a   Meng, Fan Yi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Allogeneic transplantation; Chronic myelogenous leukemia; Donor; Graft vs. host disease prophylaxis

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERIAL INFECTION; BRONCHIOLITIS; CANCER SURVIVAL; CATARACT; CHINA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOMEGALOVIRUS PNEUMONIA; DISEASE FREE SURVIVAL; DONOR; ESOPHAGUS CARCINOMA; FEMALE; GRAFT VERSUS HOST REACTION; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC CYSTITIS; HLA MATCHING; HLA TYPING; HUMAN; INCIDENCE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NEPHROTIC SYNDROME; OVERALL SURVIVAL; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROGNOSIS; PYREXIA IDIOPATHICA; QUALITY OF LIFE; RECURRENCE RISK; SECOND CANCER; SIBLING; SYSTEMIC MYCOSIS; TUBERCULOSIS; UNRELATED DONOR; VIRUS INFECTION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHINA; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; MIDDLE AGED; RECURRENCE; SIBLINGS; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79951675978     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1081-3     Document Type: Article

References (31)

1. HF Fernandez MA Kharfan-Dabaja 2009 Tyrosine kinase inhibitors and allogeneic hematopoietic cell transplantation for chronic myeloid leukemia: targeting both therapeutic modalities Cancer Control 16 2 153 157 19337201
2. M Baccarani G Saglio J Goldman, et al. 2006 Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European leukemianet Blood 108 6 1809 1820 1:CAS:528: DC%2BD28Xpsl2isrc%3D 10.1182/blood-2006-02-005686 16709930 (Pubitemid 44394987)
3. JM Goldman 2008 Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007 Bone Marrow Transplant 42 Suppl 1 S11 S13 10.1038/bmt.2008.105 18724281
4. BJ Druker CL Sawyers H Kantarjian, et al. 2001 Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 344 1038 1042 1:CAS:528:DC%2BD3MXivFGnu7o%3D 10.1056/ NEJM200104053441402 11287973 (Pubitemid 32267973)
5. NP Shah 2008 Advanced CML: therapeutic options for patients in accelerated and blast phases J Natl Compr Canc Netw 6 Suppl 2 S31 S36 1:CAS:528:DC%2BD1cXovVertbg%3D 18397679
6. E Jabbour JE Cortes FJ Giles, et al. 2007 Current and emerging treatment options in chronic myeloid leukemia Cancer 109 11 2171 2181 1:CAS:528: DC%2BD2sXmvVKjsL0%3D 10.1002/cncr.22661 17431887 (Pubitemid 46801546)
7. JX Wang 2010 The expert consensus of the treatment of chronic myeloid leukemia in China Chin J Hematol 31 3 214 215
8. JX Wang XJ Huang DP Wu, et al. 2009 Overview of chronic myelogenous leukemia and its current diagnisis and treatment patterns in 15 hospitals in China Chin J Hematol 30 11 721 725
9. R Szydlo JM Goldman JP Klein, et al. 1997 Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings J Clin Oncol 15 1767 1777 1:STN:280:DyaK2szgs12luw%3D%3D 9164184 (Pubitemid 27209503)
10. DJ Weisdorf C Anasetti JH Antin, et al. 2002 Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation Blood 99 1971 1977 1:CAS:528:DC%2BD38XitF2nt7g%3D 10.1182/blood.V99.6.1971 11877268 (Pubitemid 34525477)
11. O Ringdén SZ Pavletic C Anasetti, et al. 2009 The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation Blood 113 13 3110 3118 10.1182/blood-2008-07-163212 19059878
12. YY Lai J Ma P Schwarzenberger, et al. 2009 Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis Bone Marrow Transplant 43 61 67 1:CAS:528:DC%2BD1MXlvFOiuw%3D%3D 10.1038/bmt.2008.265 18724395
13. N Basara H Baurmann K Kolbe, et al. 2005 Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group Bone Marrow Transplant 35 1011 1018 1:CAS:528: DC%2BD2MXjvVans7Y%3D 10.1038/sj.bmt.1704957 15821768 (Pubitemid 40711839)
14. DP Lu LJ Dong T Wu, et al. 2006 Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation Blood 107 3065 3073 1:CAS:528:DC%2BD28Xjs1OlurY%3D 10.1182/blood-2005-05-2146 16380454
15. QF Liu ZP Fan J Sun, et al. 2006 Comparison between two proposal of graft-versus-host disease prophylaxis in unrelated donor hematopoietic stem cell transplantation Chin J Hematol 27 8 550 552
16. M Schleuning D Judith Z Jedlickova, et al. 2009 Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study Bone Marrow Transplant 43 717 723 1:CAS:528:DC%2BD1MXlvVGrsLw%3D 10.1038/bmt.2008.377 19011660
17. Sullivan KM (2004) Graft-versus-host-disease. In: Blume KG, Forman SJ, Appelbaum FR (eds) Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell, Malden, pp 635-664
18. A Gratwohl J Hermans JM Goldman, et al. 1998 Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Lancet 352 1087 1092 1:STN:280:DyaK1M%2Fht12htQ%3D%3D 10.1016/S0140-6736(98)03030-X 9798583 (Pubitemid 28448513)
19. CC Schag RL Heinrich PA Ganz 1984 Karnofsky performance status revisited: reliability, validity, and guidelines J Clin Oncol 2 3 187 193 1:STN:280:DyaL2c7jslyrtw%3D%3D 6699671 (Pubitemid 14138407)
20. M Arora DJ Weisdorf SR Spellman, et al. 2009 HLA-Identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia J Clin Oncol 279 10 1644 1652 10.1200/JCO.2008.18.7740
21. M Guo Z Sun QY Sun, et al. 2009 A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD Biol Blood Marrow Transplant 15 8 930 937 10.1016/j.bbmt.2009.04.006 19589482
22. A Marmont M Horowitz R Gale, et al. 1991 T cell depletion of HLA-identical transplants in leukemia Blood 78 2120 2130 1:STN:280: DyaK38%2Fgtl2lug%3D%3D 1912589
23. JL Ferrara JE Levine P Reddy, et al. 2009 Graft-versus-host disease Lancet 373 9674 1550 1561 1:CAS:528:DC%2BD1MXltlaqurk%3D 10.1016/S0140-6736(09) 60237-3 19282026
24. M Robin P Guardiola A Devergie, et al. 2005 A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors Leukemia 19 1613 1620 1:STN:280:DC%2BD2MvltFeksQ%3D%3D 10.1038/sj.leu.2403821 15990868 (Pubitemid 43090406)
25. N Fehse B Fehse N Kroger, et al. 2003 Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation J Hematother Stem Cell Res 12 237 242 10.1089/152581603321628377 12804182 (Pubitemid 36529574)
26. JP Radich T Gooley W Bensinger, et al. 2003 HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen Blood 102 31 35 1:CAS:528:DC%2BD3sXltFemtLo%3D 10.1182/blood-2002-08-2619 12595317 (Pubitemid 36759632)
27. DJ DeAngelo EP Hochberg EP Alyea, et al. 2004 Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease Clin Cancer Res 10 5065 5071 1:CAS:528:DC%2BD2cXmtlSit7o%3D 10.1158/1078-0432. CCR-03-0580 15297408 (Pubitemid 39099780)
28. C Guglielmi W Arcese F Dazzi, et al. 2002 Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose Blood 100 397 405 1:CAS:528:DC%2BD38XlsVWgtr4%3D 10.1182/blood.V100.2.397 12091328 (Pubitemid 34761099)
29. BN Savani A Montero R Kurlander, et al. 2005 Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation Bone Marrow Transplant 36 11 1009 1015 1:CAS:528:DC%2BD2MXht1WisrnL 10.1038/sj.bmt.1705167 16205732 (Pubitemid 41741565)
30. K Scott Baker JG Gurney KK Ness, et al. 2004 Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the bone marrow transplant survivor study Blood 104 1898 1906 10.1182/blood-2004-03-1010 15172972 (Pubitemid 39202304)
31. PB McGlave XO Shu WQ Wen, et al. 2000 Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program Blood 95 2219 2225 1:CAS:528:DC%2BD3cXitFeisbc%3D 10733488 (Pubitemid 30167717)